Pomalidomide: A Prescription Agent for Multiple Myeloma
Created 1 week ago by marykudro

Pomalidomide is a prescription agent, taken along with dexamethasone, approved to treat adult patients with MM who have previously received at least 2 agents, including a PI and lenalidomide. The pomalidomide 4 mg price in India is around Rs. 15,946 for a supply of 21 capsules. Pomalidomide specifically offers multiple ways to fight MM (Multiple Myeloma). This agent is a once-daily capsule, not an injection/infusion, taken on days 1 to 21 out of a 28-day cycle or as directed by your healthcare professional. It is not specified if this medication is safe and effective in children.

https://www.ikrispharmanetwork.com/pomalidomide-pomalid/